The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...

The US Food and Drug Administration has approved Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 years and older with moderate-to-severe atopic dermatitis.

Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology, today announced its participation in ...

Introduction: Eczema, also known as atopic dermatitis, is a common skin condition characterized by dry, itchy skin. While ...

I also included their recommendation for the best body lotions for mature skin along with highly rated options. SKIP AHEAD How I picked the best body lotions for mature skin | The best body lotions ...

Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...

(Reuters) -The U.S. Food and Drug Administration has approved Elanco Animal Health's skin disease treatment for dogs, the ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

Ad hoc announcement pursuant to Art. 53 LR Galderma today announced that it has signed a ...

Researchers have been able to identify whether patients with atopic dermatitis who receive dupilumab treatment will respond ...

Don’t let eczema control your child's life! Discover expert tips on managing atopic dermatitis for a happier, itch-free ...